Khaled Abouzid

Cited by

	All	Since 2019
Citations	4597	2994
h-index	38	32
i10-index	96	78

620

310

155

465

19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202415 16 16 13 26 12 23 32 44 37 42 53 71 72 92 123 131 147 186 198 224 318 391 490 610 573 599

Public access

View all

10 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Deena S. LasheenDepartment of Pharmaceutical Chemistry, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Dalal Abou El EllaFaculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Eman DoklaFaculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Sandra N MilikLecturer assistant, department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ainshams UniversityVerified email at pharma.asu.edu.eg
Amal Kamal Abdel-AzizAssociate Professor of Pharmacology & Toxicology, ASUVerified email at pharma.asu.edu.eg
Nahla FaragProfessor of Pharmaceutical Medicinal Chemistry, Misr International UniversityVerified email at miuegypt.edu.eg
Nadia Abdalla KhalilProfessor of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo UniversityVerified email at pharma.cu.edu.eg
Ashraf AbadiProfessor, Former Dean, Faculty of Pharmacy and Biotechnology, German University in CairoVerified email at guc.edu.eg
Ahmed EsmatProfessor of Pharmacology & Toxicology, Faculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Khairia M. YoussefFuture University in EgyptVerified email at fue.edu.eg
samar mowafyMisr International UniversityVerified email at miuegypt.edu.eg
Moustafa El-ArabyVirginia Commonwealth UniversityVerified email at vcu.edu
Feng WangProfessor of Chemistry, Swinburne University of Technology, AustraliaVerified email at swin.edu.au
Abdel Nasser B.SingabFormer- Vice President for Postgraduate and Research - Ain Shams Uni- Chairman of Drug DiscoveryVerified email at pharma.asu.edu.eg
Mai F. TolbaPharmacology and Toxicology, Faculty of Pharmacy, Ain Shams UniversityVerified email at pharma.asu.edu.eg
Vincenzo Di MarzoConsiglio nazionale delle RicercheVerified email at icb.cnr.it
Tamer M. IbrahimAssociate Professor, Kafrelsheikh UniversityVerified email at pharm.kfs.edu.eg
Samia Shoumannational cancer institute, cairo universityVerified email at nci.cu.edu.eg
Khaled BarakatUniversity of AlbertaVerified email at ualberta.ca
Heba Mohammed HeshamAin Shams universityVerified email at pharma.asu.edu.eg

Khaled Abouzid

professor of pharmaceutical chemistry

Verified email at pharma.asu.edu.eg - Homepage

pharmaceutical and medicinal chemistry


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand AD Khanolkar, V Abadji, S Lin, WAG Hill, G Taha, K Abouzid, Z Meng, ... Journal of medicinal chemistry 39 (22), 4515-4519, 1996	208	1996
Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase W Lang, C Qin, S Lin, AD Khanolkar, A Goutopoulos, P Fan, K Abouzid, ... Journal of medicinal chemistry 42 (5), 896-902, 1999	159	1999
Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents MA Aziz, RAT Serya, DS Lasheen, AK Abdel-Aziz, A Esmat, AM Mansour, ... Scientific reports 6 (1), 24460, 2016	158	2016
Synthesis of certain substituted quinoxalines as antimicrobial agents (part II) MM Badran, KAM Abouzid, MHM Hussein Archives of pharmacal research 26, 107-113, 2003	155	2003
Design and Synthesis of New Tetrazolyl- and Carboxy-biphenylylmethyl-quinazolin-4-one Derivatives as Angiotensin II AT₁ Receptor Antagonists MAH Ismail, S Barker, DA Abou El Ella, KAM Abouzid, RA Toubar, ... Journal of medicinal chemistry 49 (5), 1526-1535, 2006	144	2006
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer HM Hesham, DS Lasheen, KAM Abouzid Medicinal Research Reviews 38 (6), 2058-2109, 2018	140	2018
Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase K Abouzid, S Shouman Bioorganic & Medicinal Chemistry 16 (16), 7543-7551, 2008	137	2008
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors AH Abadi, TM Ibrahim, KM Abouzid, J Lehmann, HN Tinsley, BD Gary, ... Bioorganic & medicinal chemistry 17 (16), 5974-5982, 2009	133	2009
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective MAW Shalaby, EME Dokla, RAT Serya, KAM Abouzid European Journal of Medicinal Chemistry 199, 112312, 2020	111	2020
Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer FM Elmenier, DS Lasheen, KAM Abouzid European journal of medicinal chemistry 183, 111718, 2019	104	2019
Pyridazinone derivatives: Design, synthesis, and in vitro vasorelaxant activity K Abouzid, MA Hakeem, O Khalil, Y Maklad Bioorganic & medicinal chemistry 16 (1), 382-389, 2008	104	2008
Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis ZSBHJ Xin Ge, Min-Hong Pan, Lin Wang, Wei Li, Chengfei Jiang, Jun He, Khaled ... cell death and disease 9, 1128, 2018	93	2018
Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity K Abouzid, SA Bekhit Bioorganic & medicinal chemistry 16 (10), 5547-5556, 2008	85	2008
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold MI Shahin, DA Abou El Ella, NSM Ismail, KAM Abouzid Bioorganic Chemistry 56, 16-26, 2014	82	2014
Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities KAM Abouzid, GH Al-Ansary, AM El-Naggar European journal of medicinal chemistry 134, 357-365, 2017	77	2017
Quinoxaline‐based scaffolds targeting tyrosine kinases and their potential anticancer activity AMS El Newahie, NSM Ismail, DA Abou El Ella, KAM Abouzid Archiv der Pharmazie 349 (5), 309-326, 2016	73	2016
Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents EZ Elrazaz, RAT Serya, NSM Ismail, DA Abou El Ella, KAM Abouzid Future Journal of Pharmaceutical Sciences 1 (2), 33-41, 2015	70	2015
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ... European Journal of Medicinal Chemistry 186, 111850, 2020	60	2020
Pyridazine based scaffolds as privileged structures in anti-cancer therapy MY Jaballah, RT Serya, K Abouzid Drug Research 67 (03), 138-148, 2017	60	2017
How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors SN Milik, DS Lasheen, RAT Serya, KAM Abouzid European Journal of Medicinal Chemistry 142, 131-151, 2017	58	2017

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors